WSJ.com: US Business
Shire Buys ViroPharma for $4.2 Billion
[unable to retrieve full-text content]Shire has agreed to buy ViroPharma for $4.2 billion, extending its bet on the market for medicines treating rare diseases.
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment